Fibrinogen receptor antagonists and their use

This invention relates to novel fused bicycle compounds of the general formula (I): , wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other ther...

Full description

Saved in:
Bibliographic Details
Main Authors ASHA KULKARNI-ALMEIDA, ELEANOR PINTO DE SOUZA, GUPTE, RAVINDRA DATTATRAYA, RADHA BHASKAR PANICKER, RAO, VADLAMUDI V.S.V, GANGOPADHYAY, ASHOK KUMAR, GOLE, GOPAL VISHNU, SRIDEVI KRISHNAN, LAL, BANSI
Format Patent
LanguageChinese
English
Published 01.08.2005
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:This invention relates to novel fused bicycle compounds of the general formula (I): , wherein the symbols are defined herein, to pharmaceutical compositions containing the compounds, processes for preparing the compounds, and to methods of using the compounds, alone or in combination with other therapeutic agents. The compounds are antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, and are therefore useful for the inhibition of platelet aggregation, and for the treatment of thrombotic diseases and other diseases.
Bibliography:Application Number: TW200493129733